Distinct pools of cAMP centre on different isoforms of adenylyl cyclase in pituitary-derived GH3B6 cells

Journal of Cell Science

Volumn 123, Issue 1, 2010, Pages 95-106

  Wachten, Sebastian ^a   Masada, Nanako ^a   Ayling, Laura Jo ^a   Ciruela, Antonio ^a   Nikolaev, Viacheslav O ^b   Lohse, Martin J ^b   Cooper, Dermot M F ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

FRET; Pituitary; Thyrotropin releasing hormone

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PROTEIN EPAC2; PROTIRELIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM TRANSPORT; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; ENZYME ACTIVATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HYPOPHYSIS CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SYNTHESIS; PROTEIN TARGETING; RAT; SENSOR; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; CALCIUM SIGNALING; CATALYTIC DOMAIN; CELL LINE; CYCLIC AMP; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MEMBRANE MICRODOMAINS; MICROSCOPY, FLUORESCENCE; MOLECULAR PROBES; PHOSPHORIC DIESTER HYDROLASES; PITUITARY GLAND, ANTERIOR; PROTEIN ENGINEERING; PROTEIN ISOFORMS; THYROTROPIN-RELEASING HORMONE;

EID: 72449131536     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.058594     Document Type: Article

References (78)

1. Aragay, A. M., Katz, A. and Simon, M. I. (1992). The G alpha q and G alpha 11 proteins couple the thyrotropin-releasing hormone receptor to phospholipase C in GH3 rat pituitary cells. J. Biol. Chem. 267, 24983-24988.
2. Bacskai, B. J., Hochner, B., Mahaut-Smith, M., Adams, S. R., Kaang, B. K., Kandel, E. R. and Tsien, R. Y. (1993). Spatially resolved dynamics of cAMP and protein kinase A subunits in Aplysia sensory neurons. Science 260, 222-226.
3. Bauman, A. L., Soughayer, J., Nguyen, B. T., Willoughby, D., Carnegie, G. K., Wong, W., Hoshi, N., Langeberg, L. K., Cooper, D. M. F., Dessauer, C. W. et al. (2006). Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes. Mol. Cell 23, 925-931.
4. 2+. Mol. Cell Endocrinol. 49, 119-128.
5. Boyajian, C. L. and Cooper, D. M. F. (1990). Potent and cooperative feedback inhibition of adenylate cyclase activity by calcium in pituitary-derived GH3 cells. Cell Calcium 11, 299-307.
6. 2+ mobilization in NCB-20 cells leading to direct inhibition of adenylylcyclase. A novel mechanism for inhibition of cAMP production. J. Biol. Chem. 266, 4995-5003.
7. Calebiro, D., Nikolaev, V. O., Gagliani, M. C., de Filippis, T., Dees, C., Tacchetti, C., Persani, L. and Lohse, M. J. (2009). Persistent cAMP-signals triggered by internalized G-protein-coupled receptors. PLoS Biol. 7, e1000172.
8. 2+/ calmodulin-stimulated enzyme expressed in discrete regions of rat brain. J. Biol. Chem. 269, 12190-12195.
9. 2+-inhibitable adenylyl cyclase in non-excitable cells. J. Biol. Chem. 270, 1149-1155.
10. Chou, J. L., Huang, C. L., Lai, H. L., Hung, A. C., Chien, C. L., Kao, Y. Y. and Chern, Y. (2004). Regulation of type VI adenylyl cyclase by Snapin, a SNAP25-binding protein. J. Biol. Chem. 279, 46271-46279.
11. Coleman, D. T., Chen, X., Sassaroli, M. and Bancroft, C. (1996). Pituitary adenylate cyclase-activating polypeptide regulates prolactin promoter activity via a protein kinase A-mediated pathway that is independent of the transcriptional pathway employed by thyrotropin- releasing hormone. Endocrinology 137, 1276-1285.
12. Cooper, D. M. F., Mons, N. and Karpen, J. W. (1995). Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 374, 421-424.
13. Crossthwaite, A. J., Ciruela, A., Rayner, T. F. and Cooper, D. M. F. (2006). A direct interaction between the N terminus of adenylyl cyclase AC8 and the catalytic subunit of protein phosphatase 2A. Mol. Pharmacol. 69, 608-617.
14. de Rooij, J., Zwartkruis, F. J. T., Verheijen, M. H. G., Cool, R. H., Nijman, S. M. B., Wittinghofer, A. and Bos, J. L. (1998). Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396, 474-477.
15. DiPilato, L. M., Cheng, X. and Zhang, J. (2004). Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. Proc. Natl. Acad. Sci. USA 101, 16513-16518.
16. Dupre, D. J., Baragli, A., Rebois, R. V., Ethier, N. and Hebert, T. E. (2007). Signalling complexes associated with adenylyl cyclase II are assembled during their biosynthesis. Cell. Signal. 19, 481-489.
17. Evans, T., Smith, M. M., Tanner, L. I. and Harden, T. K. (1984). Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms. Mol. Pharmacol. 26, 395-404.
18. 2+ entry sites. J. Biol. Chem. 271, 12438-12444.
19. 2+ entry. J. Biol. Chem. 273, 9297-9305.
20. 2+ entry requires localization in cholesterol-rich domains. J. Biol. Chem. 275, 26530-26537.
21. Gautvik, K. M., Gordeladze, J. O., Jahnsen, T., Haug, E., Hansson, V. and Lystad, E. (1983). Thyroliberin receptor binding and adenylyl cyclase activation in cultured prolactin-producing rat pituitary tumor cells (GH cells). J. Biol. Chem. 258, 10304-10311.
22. Gershengorn, M. C. (1986). Mechanism of thyrotropin releasing hormone stimulation of pituitary hormone secretion. Annu. Rev. Physiol. 48, 515-526.
23. Guild, S. and Drummond, A. H. (1983). Adenosine 3′,5′-cyclic monophosphate-dependent release of prolactin from GH3 pituitary tumour cells. A quantitative analysis. Biochem. J. 216, 551-557.
24. Guild, S. and Drummond, A. H. (1984). Vasoactive-intestinal-polypeptide-stimulated adenosine 3′,5′-cyclic monophosphate accumulation in GH3 pituitary tumour cells. Reversal of desensitization by forskolin. Biochem. J. 221, 789-796.
25. Hayakawa, J., Ohmichi, M., Tasaka, K., Kanda, Y., Adachi, K., Nishio, Y., Hisamoto, K., Mabuchi, S., Hinuma, S. and Murata, Y. (2002). Regulation of the PRL promoter by Akt through cAMP response element binding protein. Endocrinology 143, 13-22.
26. Head, B. P., Patel, H. H., Roth, D. M., Murray, F., Swaney, J. S., Niesman, I. R., Farquhar, M. G. and Insel, P. A. (2006). Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J. Biol. Chem. 281, 26391-26399.
27. Hempel, C. M., Vincent, P., Adams, S. R., Tsien, R. Y. and Selverston, A. I. (1996). Spatio-temporal dynamics of cyclic AMP signals in an intact neural circuit. Nature 384, 166-169.
28. Herbert, J. M., Augereau, J. M., Gleye, J. and Maffrand, J. P. (1990). Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Comm. 172, 993-999.
29. Herget, S., Lohse, M. J. and Nikolaev, V. O. (2008). Real-time monitoring of phosphodiesterase inhibition in intact cells. Cell. Signal. 20, 1423-1431.
30. Iancu, R. V., Ramamurthy, G., Warrier, S., Nikolaev, V. O., Lohse, M. J., Jones, S. W. and Harvey, R. D. (2008). Cytoplasmic cAMP concentrations in intact cardiac myocytes. Am. J. Physiol. Cell Physiol. 295, C414-C422.
31. Kaupp, U. B. and Seifert, R. (2001). Molecular diversity of pacemaker ion channels. Annu. Rev. Physiol. 63, 235-257.
32. Kievit, P., Lauten, J. D. and Maurer, R. A. (2001). Analysis of the role of the mitogen-activated protein kinase in mediating cyclic-adenosine 3′,5′-monophosphate effects on prolactin promoter activity. Mol. Endocrinol. 15, 614-624.
33. Kiley, S. C., Parker, P. J., Fabbro, D. and Jaken, S. (1991). Differential regulation of protein kinase C isozymes by thyrotropin-releasing hormone in GH4C1 cells. J. Biol. Chem. 266, 23761-23768.
34. Kretschmannova, K., Gonzalez-Iglesias, A. E., Tomic, M. and Stojilkovic, S. S. (2006). Dependence of hyperpolarisation-activated cyclic nucleotide-gated channel activity on basal cyclic adenosine monophosphate production in spontaneously firing GH3 cells. J. Neuroendocrinol. 18, 484-493.
35. Lin, J.-H., Jang, Y.-C., Wen, D.-C. and Wang, F.-F. (1996). Synergistic activation of cAMP and calcium on cAMP-response-element-mediated gene expression in GH3 pituitary tumor cells. Cell. Signal. 8, 111-115.
36. + channels. Chin. J. Physiol. 49, 1-13.
37. 2+/CaM binding and autoinhibition. J. Biol. Chem. 23, 15573-15588.
38. 2+ entry via Orai1 and stromal interacting molecule 1 (STIM1) regulates adenylyl cyclase type 8. Mol. Pharmacol. 75, 830-842.
39. 2+/calmodulin of type 1 and 8 adenylyl cyclases support their different physiological roles. J. Biol. Chem. 284, 4451-4463.
40. Mei, F. C., Qiao, J., Tsygankova, O. M., Meinkoth, J. L., Quilliam, L. A. and Cheng, X. (2002). Differential signaling of cyclic AMP: opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation. J. Biol. Chem. 277, 11497-11504.
41. Neufeld, E. B., Cooney, A. M., Pitha, J., Dawidowicz, E. A., Dwyer, N. K., Pentchev, P. G. and Blanchette-Mackie, E. J. (1996). Intracellular trafficking of cholesterol monitored with a cyclodextrin. J. Biol. Chem. 271, 21604-21613.
42. Nikolaev, V. O., Bunemann, M., Hein, L., Hannawacker, A. and Lohse, M. J. (2004a). Novel single chain cAMP sensors for receptor-induced signal propagation. J. Biol. Chem. 279, 37215-37218.
43. Nikolaev, V. O., Gambaryan, S., Engelhardt, S., Walter, U. and Lohse, M. J. (2004b). Real-time monitoring of live cell's PDE2 activity: Hormone-stimulated cAMP hydrolysis is faster than hormone-stimulated cAMP synthesis. J. Biol. Chem. 3, 1716-1719.
44. Nikolaev, V. O., Bunemann, M., Schmitteckert, E., Lohse, M. J. and Engelhardt, S. (2006). Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling. Circ. Res. 99, 1084-1091.
45. Onali, P., Eva, C., Olianas, M. C., Schwartz, J. P. and Costa, E. (1983). In GH3 pituitary cells, acetylcholine and vasoactive intestinal peptide antagonistically modulate adenylate cyclase, cyclic AMP content, and prolactin secretion. Mol. Pharmacol. 24, 189-194.
46. Ooi, G. T., Tawadros, N. and Escalona, R. M. (2004). Pituitary cell lines and their endocrine applications. Mol. Cell. Endocrinol. 228, 1-21.
47. Pagano, M., Clynes, M. A., Masada, N., Ciruela, A., Ayling, L.-J., Wachten, S. and Cooper, D. M. F. (2009). Insights into the residence in lipid rafts of adenylyl cyclase AC8 and its regulation by capacitative calcium entry. Am. J. Physiol. Cell Physiol. 296, C607-C619.
48. Parekh, A. B. and Putney, J. W., Jr (2005). Store-operated calcium channels. Physiol. Rev. 85, 757-810.
49. Paulssen, R. H., Paulssen, E. J., Gautvik, K. M. and Gordeladze, J. O. (1992). The thyroliberin receptor interacts directly with a stimulatory guanine-nucleotide-binding protein in the activation of adenylyl cyclase in GH3 rat pituitary tumour cells. Evidence obtained by the use of antisense RNA inhibition and immunoblocking of the stimulatory guanine-nucleotide-binding protein. Eur. J. Biochem. 204, 413-418.
50. Paulssen, R. H., Johansen, P. W., Gordeladze, J. O., Nymoen, O., Paulssen, E. J. and Gautvik, K. M. (1994). Cell-specific expression and function of adenylyl cyclases in rat pituitary tumour cell lines. Eur. J. Biochem. 222, 97-103.
51. Perez, F. M., Rose, J. C. and Schwartz, J. (1995). Anterior pituitary cells: getting to know their neighbors. Mol. Cell Endocrinol. 111, C1-C6.
52. Piggott, L. A., Bauman, A. L., Scott, J. D. and Dessauer, C. W. (2008). The A-kinase anchoring protein Yotiao binds and regulates adenylyl cyclase in brain. Proc. Natl. Acad. Sci. USA 105, 13835-13840.
53. Pike, L. J. (2003). Lipid rafts: bringing order to chaos. J. Lipid. Res. 44, 655-667.
54. Ponsioen, B., Zhao, J., Riedl, J., Zwartkruis, F., van der Krogt, G., Zaccolo, M., Moolenaar, W. H., Bos, J. L. and Jalink, K. (2004). Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO Rep. 5, 1176-1180.
55. Putney, J. W., Jr (2001). The pharmacology of capacitative calcium entry. Mol. Interv. 1, 84-94.
56. Rajendran, L. and Simons, K. (2005). Lipid rafts and membrane dynamics. J. Cell Sci. 118, 1099-1102.
57. Resh, M. D. (2006). Trafficking and signaling by fatty-acylated and prenylated proteins. Nat. Chem. Biol. 2, 584-590.
58. Rich, T. C., Fagan, K. A., Tse, T. E., Schaack, J., Cooper, D. M. F. and Karpen, J. W. (2001). A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell. Proc. Natl. Acad. Sci. USA. 98, 13049-13054.
59. 2+ in clonal pituitary cells (GH3 cells): direct evidence for the mobilization of cellular calcium. J. Cell Biol. 99, 83-87.
60. Simons, K. and Ikonen, E. (1997). Functional rafts in cell membranes. Nature 387, 569-572.
61. Smallridge, R. C., Kiang, J. G., Gist, I. D., Fein, H. G. and Galloway, R. J. (1992). U-73122, an aminosteroid phospholipase C antagonist, noncompetitively inhibits thyrotropin-releasing hormone effects in GH3 rat pituitary cells. Endocrinology 131, 1883-1888.
62. 2+ entry. J. Biol. Chem. 277, 6025-6031.
63. 2+-inhibitable adenylyl cyclase modulates pulmonary artery endothelial cell cAMP content and barrier function. Proc. Natl. Acad. Sci. USA 92, 2696-2700.
64. Sunahara, R. K. and Taussig, R. (2002). Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. Mol. Interv. 2, 168-184.
65. Tashjian, A. H., Jr (1979). Clonal strains of hormone-producing pituitary cells. Methods Enzymol. 58, 527-535.
66. Tesmer, J. J. G., Sunahara, R. K., Johnson, R. A., Gosselin, G., Gilman, A. G. and Sprang, S. R. (1999). Two-metal-ion catalysis in adenylyl cyclase. Science. 285, 756-760.
67. Wachten, S., Schlenstedt, J., Gauss, R. and Baumann, A. (2006). Molecular identification and functional characterization of an adenylyl cyclase from the honeybee. J. Neurochem. 96, 1580-1590.
68. Wang, Y.-H. and Maurer, R. A. (1999). A role for the mitogen-activated protein kinase in mediating the ability of thyrotropin-releasing hormone to stimulate the prolactin promoter. Mol. Endocrinol. 13, 1094-1104.
69. 2+ stimulation of cAMP accumulation in mouse parotid acini. J. Biol. Chem. 275, 14691-14699.
70. 2+ stimulation of adenylyl cyclase generates dynamic oscillations in cyclic AMP. J. Cell Sci. 119, 828-836.
71. 2+ regulation of adenylyl cyclases in cAMP microdomains. Physiol. Rev. 87, 965-1010.
72. Willoughby, D. and Cooper, D. M. F. (2008). Live-cell imaging of cAMP dynamics. Nat. Meth. 5, 29-36.
73. Willoughby, D., Wong, W., Schaack, J., Scott, J. D. and Cooper, D. M. F. (2006). An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics. EMBO J. 25, 2051-2061.
74. Winiger, B. P. and Schlegel, W. (1988). Rapid transient elevations of cytosolic calcium triggered by thyrotropin releasing hormone in individual cells of the pituitary line GH3B6. Biochem. J. 255, 161-167.
75. Yoshimura, M. and Cooper, D. M. F. (1993). Type-specific stimulation of adenylylcyclase by protein kinase C. J. Biol. Chem. 268, 4604-4607.
76. Zaccolo, M. and Pozzan, T. (2002). Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295, 1711-1715.
77. Zacharias, D. A., Violin, J. D., Newton, A. C. and Tsien, R. Y. (2002). Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 296, 913-916.
78. Zyzek, E., Desmazes, J. P., Gourdji, D., Dufy, B. and Georgescauld, D. (1983). Modifications of membrane cholesterol content affects electrical properties and prolactin release of cultured pituitary cells. Experientia 39, 56-58.